The independent ISREC Foundation, which for 45 years shepherded the independent ISREC Institute before its integration into EPFL in 2008, is now focused on supporting innovative cancer research in Lausanne and Western Switzerland, in particular at the frontier of translational oncology that has promise to positively impact the future treatment of cancer patients. Notably the ISREC Foundation has courageously implemented the design, funding, and construction of the visionary new AGORA translational cancer research building, aiming to expedite progress toward innovative new cancer therapies.
